Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rustam Al-Shahi Salman

Showing results (241-250 of 302) with videos related to

Pageof 31
Sort By:
The Lancet. Neurology|May 27, 2019
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trialRustam Al-Shahi Salman, David P Minks, Dipayan Mitra, et al.
Journal of the American Heart Association|February 15, 2021
Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled TrialZhe Kang Law, Michael Desborough, Ian Roberts, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 20, 2016
Reliability of intracerebral hemorrhage classification systems: A systematic reviewKristiina Rannikmäe, Rebecca Woodfield, Craig S Anderson, et al.
The Lancet. Neurology|June 21, 2020
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trialJay P Mohr, Jessica R Overbey, Andreas Hartmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 29, 2016
Genome-wide association study of sporadic brain arteriovenous malformationsShantel Weinsheimer, Nasrine Bendjilali, Jeffrey Nelson, et al.
JACC. Advances|April 30, 2025
Targeting Investigation and Treatment in Type 2 Myocardial Infarction: A Pilot Randomized Controlled TrialCaelan Taggart, Amy Ferry, Stephanie Barker, et al.
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.
BMJ Neurology Open|June 20, 2023
Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trialJason Philip Appleton, Zhe Kang Law, Lisa Jane Woodhouse, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 7, 2016
Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trialNikola Sprigg, Katie Robson, Philip Bath, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Pageof 31

Showing results (241-250 of 302) with videos related to

Sort By:
Pageof 31
The Lancet. Neurology|May 27, 2019
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trialRustam Al-Shahi Salman, David P Minks, Dipayan Mitra, et al.
Journal of the American Heart Association|February 15, 2021
Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled TrialZhe Kang Law, Michael Desborough, Ian Roberts, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 20, 2016
Reliability of intracerebral hemorrhage classification systems: A systematic reviewKristiina Rannikmäe, Rebecca Woodfield, Craig S Anderson, et al.
The Lancet. Neurology|June 21, 2020
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trialJay P Mohr, Jessica R Overbey, Andreas Hartmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 29, 2016
Genome-wide association study of sporadic brain arteriovenous malformationsShantel Weinsheimer, Nasrine Bendjilali, Jeffrey Nelson, et al.
JACC. Advances|April 30, 2025
Targeting Investigation and Treatment in Type 2 Myocardial Infarction: A Pilot Randomized Controlled TrialCaelan Taggart, Amy Ferry, Stephanie Barker, et al.
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.
BMJ Neurology Open|June 20, 2023
Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trialJason Philip Appleton, Zhe Kang Law, Lisa Jane Woodhouse, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 7, 2016
Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trialNikola Sprigg, Katie Robson, Philip Bath, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Pageof 31